Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis
Completed
- Conditions
- DiabetesEnd Stage Renal Disease
- Interventions
- Device: Continuous Glucose Monitoring (CGM)
- Registration Number
- NCT01049152
- Lead Sponsor
- University of Pavia
- Brief Summary
Evaluation of different glycemic variations between the dialysis period and non-dialysis period in two groups: nondiabetic and diabetic patients undergone two different hemodialysis methods. Thirty-six patients, males and females, aged 50-80 years, with end stage renal disease (ESRD) will undergo hemodialysis and continuous glucose monitoring (CGM). The investigators will evaluate also inflammation markers before and after the different hemodialysis methods.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
- patients with or without diabetes mellitus
- ESRD
- undergone hemodialysis
- males and females aged 50-80
Exclusion Criteria
- tumors
- chronic inflammation diseases
- AMI
- acute pulmonary diseases
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description nondiabetic patients Continuous Glucose Monitoring (CGM) nondiabetic patients with ESRD undergone hemodialysis diabetic patients Continuous Glucose Monitoring (CGM) diabetic patients with ESRD undergone hemodialysis
- Primary Outcome Measures
Name Time Method -Hemodialysis tolerability -Hypoglycemia numbers -Hyperglycemia numbers -Inflammation markers before and after each procedure
- Secondary Outcome Measures
Name Time Method variations of glycemia during the night; insulin-sensitivity at the beginning of the first hemodialysis and at the end of the second hemodialysis
Trial Locations
- Locations (1)
IRCCS Policlinico San Matteo
🇮🇹Pavia, Italy